| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.006 | 214.521 | 521.379 | 348.523 | - |
| Total Income - EUR | - | - | - | - | - | 2.006 | 215.535 | 522.474 | 349.049 | - |
| Total Expenses - EUR | - | - | - | - | - | 2.263 | 156.515 | 429.284 | 315.270 | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | -257 | 59.020 | 93.190 | 33.779 | - |
| Net Profit/Loss - EUR | - | - | - | - | - | -317 | 55.958 | 88.750 | 30.468 | - |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | - |
Check the financial reports for the company - Medilogic Chemical Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 23 | 0 | 47.612 | 1.755 | - |
| Current Assets | - | - | - | - | - | 2.578 | 148.394 | 104.462 | 95.883 | - |
| Inventories | - | - | - | - | - | 1.471 | 15.305 | 17.897 | 46.841 | - |
| Receivables | - | - | - | - | - | 490 | 121.321 | 83.315 | 39.575 | - |
| Cash | - | - | - | - | - | 617 | 11.769 | 3.250 | 9.467 | - |
| Shareholders Funds | - | - | - | - | - | -276 | 55.688 | 144.611 | 68.456 | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | - | - | 2.877 | 92.706 | 7.463 | 29.170 | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 12 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medilogic Chemical Center S.r.l.